Alexander G. Mathioudakis is a Clinical Research Fellow and Honorary Lecturer in Respiratory Medicine, at the University of Manchester and Manchester University NHS Foundation Trust. His research focuses on Airway Diseases phenotypes and personalised medicine, as well as clinical research methodology and evidence based medicine.
He graduated from the Medical School of National and Kapodistrian University of Athens (Greece, 2011) and started his clinical training in Respiratory and General Internal Medicine in Health Education North West. He undertook a Fellowship in Guidelines Methodology at Cochrane Iberoamerica and NICE (European Respiratory Society-ERS, 2016), followed by an Academic Clinical Fellowship in Respiratory Medicine at the University of Manchester (NIHR, 2016-2018) and a PhD Studentship by the NIH Manchester Biomedical Reseach Centre (BRC, 2018-).
He has published over 40 peer review publications and has an h-index of 14 in Google Scholar. He has contributed to the development of the 2019 update of the British guideline on the management of asthma (SIGN/BTS, 2019). He is also involved in the development of the BTS Guidelines on Pulmonary Rehabilitation (ongoing), ERS Guidelines on Sarcoidosis management (ongoing) and two methodological guidelines by GRADE on the conduct of systematic reviews (GRADE 17 & an ongoing guideline). He has received research funding for investigator initiated studies by Boehringer Ingelheim and the North West Lung Charity.
He periodically reviews grant proposals for National Institute for Health Research (NIHR-UK), Health Research Board (HBR-Ireland), and the European Respiratory Society (ERS). He is an Associate Editor of the Cochrane Database of Systematic Reviews and Folia Medica and a member of the editorial board of Archives of Hellenic Medicine. He regularly peer reviews manuscripts for the BMJ, ERJ, AJRCCM, Chest, Allergy and other leading journals. He is a member of the ERS and BTS Guideline Working Groups and the co-chair of an ERS/EAACI task force on asthma management and of an ERS task force on COPD exacerbations.